Bio-Techne Corp (TECH)
71.28
+0.23
(+0.32%)
USD |
NASDAQ |
Nov 22, 16:00
71.28
0.00 (0.00%)
After-Hours: 20:00
Bio-Techne Revenue (Quarterly): 289.46M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 289.46M |
| June 30, 2024 | 306.10M |
| March 31, 2024 | 303.43M |
| December 31, 2023 | 272.60M |
| September 30, 2023 | 276.94M |
| June 30, 2023 | 301.32M |
| March 31, 2023 | 294.15M |
| December 31, 2022 | 271.58M |
| September 30, 2022 | 269.66M |
| June 30, 2022 | 288.23M |
| March 31, 2022 | 290.38M |
| December 31, 2021 | 269.28M |
| September 30, 2021 | 257.72M |
| June 30, 2021 | 259.03M |
| March 31, 2021 | 243.55M |
| December 31, 2020 | 224.25M |
| September 30, 2020 | 204.20M |
| June 30, 2020 | 175.83M |
| March 31, 2020 | 194.68M |
| December 31, 2019 | 184.93M |
| September 30, 2019 | 183.24M |
| June 30, 2019 | 191.66M |
| March 31, 2019 | 184.86M |
| December 31, 2018 | 174.51M |
| September 30, 2018 | 162.97M |
| Date | Value |
|---|---|
| June 30, 2018 | 180.25M |
| March 31, 2018 | 163.97M |
| December 31, 2017 | 154.15M |
| September 30, 2017 | 144.61M |
| June 30, 2017 | 156.58M |
| March 31, 2017 | 144.04M |
| December 31, 2016 | 131.81M |
| September 30, 2016 | 130.58M |
| June 30, 2016 | 134.76M |
| March 31, 2016 | 130.97M |
| December 31, 2015 | 120.91M |
| September 30, 2015 | 112.38M |
| June 30, 2015 | 117.66M |
| March 31, 2015 | 114.16M |
| December 31, 2014 | 111.95M |
| September 30, 2014 | 108.48M |
| June 30, 2014 | 92.52M |
| March 31, 2014 | 95.56M |
| December 31, 2013 | 84.02M |
| September 30, 2013 | 85.67M |
| June 30, 2013 | 79.48M |
| March 31, 2013 | 80.99M |
| December 31, 2012 | 75.08M |
| September 30, 2012 | 75.02M |
| June 30, 2012 | 78.68M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
175.83M
Minimum
Jun 2020
306.10M
Maximum
Jun 2024
258.86M
Average
270.62M
Median
Revenue (Quarterly) Benchmarks
| Bio-Rad Laboratories Inc | 649.73M |
| Boston Scientific Corp | 4.209B |
| ResMed Inc | 1.225B |
| Zimmer Biomet Holdings Inc | 1.824B |
| AIM ImmunoTech Inc | 0.035M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 33.60M |
| Total Expenses (Quarterly) | 249.47M |
| EPS Diluted (Quarterly) | 0.21 |
| Enterprise Value | 11.44B |
| Gross Profit Margin (Quarterly) | 63.23% |
| Profit Margin (Quarterly) | 11.61% |
| Earnings Yield | 1.32% |
| Operating Earnings Yield | 1.98% |
| Normalized Earnings Yield | 1.647 |